Grants | United States

At this time, Biogen is not accepting grant submissions in the United States via the standard quarterly submission cycles. Please monitor Areas of Interest for the most up-to-date information.

Medical Education

Funding to an eligible institution or organization to support independent medical educational activities for HCPs and researchers. Medical education may be accredited or non-accredited.

 

 

Areas of Interest and Requests for Educational Support

Areas of Interest

At this time, Biogen is not accepting medical education grant submissions via the standard quarterly submission cycles.

Requests for Educational Support

Biogen seeks to close important medical education gaps through consideration of grant proposals in the following disease areas:
 

ALZHEIMER’S DISEASE
RFE ID: RFE-21-AD-001
Submission Deadline: June 3, 2021

Biogen invites accredited members of the educational provider community to submit applications for independent, certified medical education grants subject to the terms described below. This request for education provides public notice of availability of funds to address areas related to the clinical assessment tools commonly used in clinical trials of disease-modifying therapies for Alzheimer’s disease.

 

AMYOTROPHIC LATERAL SCLEROSIS
RFE ID: RFE-21-ALS-001
Submission Deadline: June 3, 2021

Biogen invites accredited members of the educational provider community to submit applications for independent, certified medical education grants subject to the terms described below. This request for education provides public notice of availability of funds to address areas related to genetic testing and the patient journey of Amyotrophic Lateral Sclerosis (ALS) patients.

 

MULTIPLE SCLEROSIS
RFE ID: RFE-21-MS-001
Submission Deadline: June 3, 2021

Biogen invites accredited members of the educational provider community to submit applications for independent, certified medical education grants subject to the terms described below. This request for education provides public notice of availability of funds to address areas related to disease modifying therapy sequencing for multiple sclerosis (MS).

 

SPINAL MUSCULAR ATROPHY
RFE ID: RFE-21-SMA-001
Submission Deadline: June 3, 2021

Biogen invites accredited members of the educational provider community to submit applications for independent, certified medical education grants subject to the terms described below. This request for education provides public notice of availability of funds to address areas related to the diagnosis and referral of Spinal Muscular Atrophy patients.
 

Application Submission Cycles

At this time, Biogen is not accepting medical education grant submissions via the standard quarterly submission cycles.

Application Requirements and Organization Eligibility

To be considered for a grant, the following criteria must be met:

  • Grant request must be unsolicited
  • Grant request must not provide tangible benefit to Biogen
  • Grant request must be submitted for a future project or program
  • Funding amount requested must reflect a real and fair market value for the proposed activities
  • Funding from other pharmaceutical/biotechnology companies, in addition to Biogen, is preferred (e.g. multiple sources of funding)
  • Funds are not granted to directly or indirectly encourage recipients to purchase or prescribe Biogen's products or services
  • Funding is permitted only to legally established organizations; a grant cannot be provided to individuals
  • Requesting organization must be registered for more than 2 years
  • Requesting organization must confirm receipt of payment and verify how funds were used for all previous Biogen supported activities
  • Requesting organization and grant request must be in full compliance with all regional and local codes, laws and industry regulations, including, but not limited to anti-corruption, transparency and privacy laws and regulations

Biogen will conduct appropriate due diligence on all requesting organizations and grant requests.

Biogen reserves the right to deny any grant request that does not meet application and eligibility requirements.

Biogen must not provide any substantive input or assistance to a requesting organization in drafting or submitting a grant request.

Biogen may modify the grant application and eligibility requirements at any time.

Due to the impact of COVID-19, a contingency plan must be submitted with all grant applications that include live programs or activities.

Funding Limitations and Restrictions

Separation from Commercial Initiatives

Grant requests from organizations that provide commercial services (e.g. marketing or promotional) to Biogen are thoroughly reviewed to ensure appropriate separation (firewalls) exists between the part of the organization providing commercial services to Biogen and the part of the organization seeking grant funding.

Third Parties

If a third-party provider will be utilized to implement the proposed project or program, the provider must not be owned in whole or in part by, or controlled by:

  • A practicing physician or other HCP
  • A group practice of physicians or other HCPs
  • An individual who is an immediate family member of a practicing physician or other HCP

Limitations and Restrictions

Funding must not be used for:

  • Travel, lodging or registration expenses for non-faculty healthcare professionals to attend a program
  • Operating expenses that are not directly and exclusively dedicated to the project or program (e.g. equipment, salaries, benefits, journal subscriptions, etc.)
  • Support of a promotional exhibit or display space/fees
    Please submit requests for exhibit fees under the Sponsorships request category
  • Stand-alone entertainment or social events
  • Staff/professional development
  • Advertising space
  • Programs that take place in a location or venue that detract from the educational activity’s primary purpose

Review Process

All grant requests are reviewed according to the published application submission cycles.

Biogen has a formal, centralized grant review and decision-making process. Several factors are considered during this process including, but not limited to, the following:

  • Alignment to areas of interest
  • Project or program format
  • Needs assessment summary
  • Educational/grant objectives
  • Target learners/participants
  • Funding amount requested
  • Proposed project or program outcomes (effectiveness)

To confirm Biogen’s independence from the requesting organization, the annual operating costs (total reportable expenses) of the organization are reviewed. The annual operating costs, which must be from either of the last 2 fiscal years, will be compared to the total funding provided to the requesting organization by Biogen on a rolling twelve (12) month-basis.

Decisions and Communications

Funding decisions for grants are based on the quality of the proposal, alignment with Biogen’s grants strategy and budget availability. Decision notifications will be communicated in writing by the Grants Management & Strategic Giving Office. No other Biogen employee is authorized to provide this information.

Contracting and Payment

All recipient organizations must abide by the terms and conditions as outlined in the Biogen Letter of Agreement (LOA)/contract. The LOA/contract is issued electronically to an authorized signatory of the organization once an application is approved. A fully executed LOA/contract is required prior to the start of the project or program.

Payment will be issued upon execution of the LOA/contract.

Project / Program Execution

Recipient organizations shall acknowledge support from Biogen in a non-promotional manner as permitted by local codes, laws and regulations.

Changes to an awarded grant (e.g. format, dates, audience), must be reviewed and approved by Biogen prior to the start of the project or program. To determine if funding may continue, organizations should submit the proposed changes to grantsandgiving@biogen.com for review.

Organizations may be asked to provide status updates and outcomes/progress reports throughout the course of the project or program's implementation.

Reconciliation

Once the project or program concludes, a reconciliation must be completed by the recipient organization. The reconciliation confirms:

  • Receipt of payment
  • Funding was used appropriately (as described in the letter of agreement/contract)
  • Grant objectives were achieved

This reconciliation must be completed and returned to the Grants Management & Strategic Giving Office within 90 days of the project or program end date.  After 90 days, the reconciliation is considered overdue.  Recipient organizations are not eligible to receive new funding until all overdue reconciliations are submitted and approved.

Transparency

Biogen adheres to global transparency and disclosure reporting obligations in accordance with local regulations.

Patient Education

Funding to an eligible institution or organization to support independent educational activities for patients or caregivers.

 

 

Areas of Interest

At this time, Biogen is not accepting patient education grant submissions.

Application Submission Cycles

At this time, Biogen is not accepting patient education grant submissions.

Application Requirements and Organization Eligibility

To be considered for a grant, the following criteria must be met:

  • Grant request must be unsolicited
  • Grant request must not provide tangible benefit to Biogen
  • Grant request must be submitted for a future project or program
  • Funding amount requested must reflect a real and fair market value for the proposed activities
  • Funding from other pharmaceutical/biotechnology companies, in addition to Biogen, is preferred (e.g. multiple sources of funding)
  • Funds are not granted to directly or indirectly encourage recipients to purchase or prescribe Biogen's products or services
  • Funding is permitted only to legally established organizations; a grant cannot be provided to individuals
  • Requesting organization must be registered for more than 2 years
  • Requesting organization must confirm receipt of payment and verify how funds were used for all previous Biogen supported activities
  • Requesting organization and grant request must be in full compliance with all regional and local codes, laws and industry regulations, including, but not limited to anti-corruption, transparency and privacy laws and regulations

Biogen will conduct appropriate due diligence on all requesting organizations and grant requests.

Biogen reserves the right to deny any grant request that does not meet application and eligibility requirements.

Biogen must not provide any substantive input or assistance to a requesting organization in drafting or submitting a grant request.

Biogen may modify the grant application and eligibility requirements at any time.

Due to the impact of COVID-19, a contingency plan must be submitted with all grant applications that include live programs or activities.

Funding Limitations and Restrictions

Separation from Commercial Initiatives

Grant requests from organizations that provide commercial services (e.g. marketing or promotional) to Biogen are thoroughly reviewed to ensure appropriate separation (firewalls) exists between the part of the organization providing commercial services to Biogen and the part of the organization seeking grant funding.

Third Parties

If a third-party provider will be utilized to implement the proposed project or program, the provider must not be owned in whole or in part by, or controlled by:

  • A practicing physician or other HCP
  • A group practice of physicians or other HCPs
  • An individual who is an immediate family member of a practicing physician or other HCP

Limitations and Restrictions

Funding must not be used for:

  • Travel, lodging or registration expenses for non-faculty healthcare professionals to attend a program
  • Operating expenses that are not directly and exclusively dedicated to the project or program (e.g. equipment, salaries, benefits, journal subscriptions, etc.)
  • Support of a promotional exhibit or display space/fees
    Please submit requests for exhibit fees under the Sponsorships request category
  • Stand-alone entertainment or social events
  • Staff/professional development
  • Advertising space
  • Programs that take place in a location or venue that detract from the educational activity’s primary purpose

Review Process

All grant requests are reviewed according to the published application submission cycles.

Biogen has a formal, centralized grant review and decision-making process. Several factors are considered during this process including, but not limited to, the following:

  • Alignment to areas of interest
  • Project or program format
  • Needs assessment summary
  • Educational/grant objectives
  • Target learners/participants
  • Funding amount requested
  • Proposed project or program outcomes (effectiveness)

To confirm Biogen’s independence from the requesting organization, the annual operating costs (total reportable expenses) of the organization are reviewed. The annual operating costs, which must be from either of the last 2 fiscal years, will be compared to the total funding provided to the requesting organization by Biogen on a rolling twelve (12) month-basis.

Decisions and Communications

Funding decisions for grants are based on the quality of the proposal, alignment with Biogen’s grants strategy and budget availability. Decision notifications will be communicated in writing by the Grants Management & Strategic Giving Office. No other Biogen employee is authorized to provide this information.

Contracting and Payment

All recipient organizations must abide by the terms and conditions as outlined in the Biogen Letter of Agreement (LOA)/contract. The LOA/contract is issued electronically to an authorized signatory of the organization once an application is approved. A fully executed LOA/contract is required prior to the start of the project or program.

Payment will be issued upon execution of the LOA/contract.

Project / Program Execution

Recipient organizations shall acknowledge support from Biogen in a non-promotional manner as permitted by local codes, laws and regulations.

Changes to an awarded grant (e.g. format, dates, audience), must be reviewed and approved by Biogen prior to the start of the project or program. To determine if funding may continue, organizations should submit the proposed changes to grantsandgiving@biogen.com for review.

Organizations may be asked to provide status updates and outcomes/progress reports throughout the course of the project or program's implementation.

Reconciliation

Once the project or program concludes, a reconciliation must be completed by the recipient organization. The reconciliation confirms:

  • Receipt of payment
  • Funding was used appropriately (as described in the letter of agreement/contract)
  • Grant objectives were achieved

This reconciliation must be completed and returned to the Grants Management & Strategic Giving Office within 90 days of the project or program end date.  After 90 days, the reconciliation is considered overdue.  Recipient organizations are not eligible to receive new funding until all overdue reconciliations are submitted and approved.

Transparency

Biogen adheres to global transparency and disclosure reporting obligations in accordance with local regulations.

General Grant

Funding to support a project or program that does not fit any of the other defined grant categories.

 

 

Areas of Interest

At this time, Biogen is not accepting general grant submissions.

Application Submission Cycles

At this time, Biogen is not accepting general grant submissions.

Application Requirements and Organization Eligibility

To be considered for a grant, the following criteria must be met:

  • Grant request must be unsolicited
  • Grant request must not provide tangible benefit to Biogen
  • Grant request must be submitted for a future project or program
  • Funding amount requested must reflect a real and fair market value for the proposed activities
  • Funding from other pharmaceutical/biotechnology companies, in addition to Biogen, is preferred (e.g. multiple sources of funding)
  • Funds are not granted to directly or indirectly encourage recipients to purchase or prescribe Biogen's products or services
  • Funding is permitted only to legally established organizations; a grant cannot be provided to individuals
  • Requesting organization must be registered for more than 2 years
  • Requesting organization must confirm receipt of payment and verify how funds were used for all previous Biogen supported activities
  • Requesting organization and grant request must be in full compliance with all regional and local codes, laws and industry regulations, including, but not limited to anti-corruption, transparency and privacy laws and regulations

Biogen will conduct appropriate due diligence on all requesting organizations and grant requests.

Biogen reserves the right to deny any grant request that does not meet application and eligibility requirements.

Biogen must not provide any substantive input or assistance to a requesting organization in drafting or submitting a grant request.

Biogen may modify the grant application and eligibility requirements at any time.

Due to the impact of COVID-19, a contingency plan must be submitted with all grant applications that include live programs or activities.

Funding Limitations and Restrictions

Separation from Commercial Initiatives

Grant requests from organizations that provide commercial services (e.g. marketing or promotional) to Biogen are thoroughly reviewed to ensure appropriate separation (firewalls) exists between the part of the organization providing commercial services to Biogen and the part of the organization seeking grant funding.

Third Parties

If a third-party provider will be utilized to implement the proposed project or program, the provider must not be owned in whole or in part by, or controlled by:

  • A practicing physician or other HCP
  • A group practice of physicians or other HCPs
  • An individual who is an immediate family member of a practicing physician or other HCP

Limitations and Restrictions

Funding must not be used for:

  • Travel, lodging or registration expenses for non-faculty healthcare professionals to attend a program
    Independent Education Grants for patient education may allow for support of reasonable travel and accommodation expenses related to patient/caregiver attendees, as determined, and where allowed by local laws and code.
  • Operating expenses that are not directly and exclusively dedicated to the project or program (e.g. equipment, salaries, benefits, journal subscriptions, etc.)
  • Support of a promotional exhibit or display space/fees
    Please submit requests for exhibit fees under the Sponsorships request category
  • Stand-alone entertainment or social events
  • Staff/professional development
  • Advertising space
  • Programs that take place in a location or venue that detract from the educational activity’s primary purpose

Review Process

All grant requests are reviewed according to the published application submission cycles.

Biogen has a formal, centralized grant review and decision-making process. Several factors are considered during this process including, but not limited to, the following:

  • Alignment to areas of interest
  • Project or program format
  • Needs assessment summary
  • Educational/grant objectives
  • Target learners/participants
  • Funding amount requested
  • Proposed project or program outcomes (effectiveness)

To confirm Biogen’s independence from the requesting organization, the annual operating costs (total reportable expenses) of the organization are reviewed. The annual operating costs, which must be from either of the last 2 fiscal years, will be compared to the total funding provided to the requesting organization by Biogen on a rolling twelve (12) month-basis.

Decisions and Communications

Funding decisions for grants are based on the quality of the proposal, alignment with Biogen’s grants strategy and budget availability. Decision notifications will be communicated in writing by the Grants Management & Strategic Giving Office. No other Biogen employee is authorized to provide this information.

Contracting and Payment

All recipient organizations must abide by the terms and conditions as outlined in the Biogen Letter of Agreement (LOA)/contract. The LOA/contract is issued electronically to an authorized signatory of the organization once an application is approved. A fully executed LOA/contract is required prior to the start of the project or program.

Payment will be issued upon execution of the LOA/contract.

Project / Program Execution

Recipient organizations shall acknowledge support from Biogen in a non-promotional manner as permitted by local codes, laws and regulations.

Changes to an awarded grant (e.g. format, dates, audience), must be reviewed and approved by Biogen prior to the start of the project or program. To determine if funding may continue, organizations should submit the proposed changes to grantsandgiving@biogen.com for review.

Organizations may be asked to provide status updates and outcomes/progress reports throughout the course of the project or program's implementation.

Reconciliation

Once the project or program concludes, a reconciliation must be completed by the recipient organization. The reconciliation confirms:

  • Receipt of payment
  • Funding was used appropriately (as described in the letter of agreement/contract)
  • Grant objectives were achieved

This reconciliation must be completed and returned to the Grants Management & Strategic Giving Office within 90 days of the project or program end date.  After 90 days, the reconciliation is considered overdue.  Recipient organizations are not eligible to receive new funding until all overdue reconciliations are submitted and approved.

Transparency

Biogen adheres to global transparency and disclosure reporting obligations in accordance with local regulations.